“COVID Arm” in the family medicine setting: Moderna vaccine hypersensitivity reaction
The Moderna COVID-19 vaccination has been widely distributed since authorized for emergency use. Phase 3 clinical trial data reported that 1.5% of recipients experienced hypersensitivity reactions after vaccination. The resulting erythematous rash, termed “COVID arm,” has been described in isolated...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Journal of Public Health and Primary Care |
| Subjects: | |
| Online Access: | http://www.jphpc.org/article.asp?issn=2772-3666;year=2022;volume=3;issue=3;spage=90;epage=92;aulast=Cohen |